BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1521721)

  • 1. Sorbinil does not prevent hyperfiltration, elevated ultrafiltration pressure and albuminuria in streptozotocin-diabetic rats.
    Körner A; Celsi G; Eklöf AC; Linné T; Persson B; Aperia A
    Diabetologia; 1992 May; 35(5):414-8. PubMed ID: 1521721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus.
    Chang WP; Dimitriadis E; Allen T; Dunlop ME; Cooper M; Larkins RG
    Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat.
    Craven PA; DeRubertis FR
    Metabolism; 1989 Jul; 38(7):649-54. PubMed ID: 2500578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.
    Tilton RG; Chang K; Pugliese G; Eades DM; Province MA; Sherman WR; Kilo C; Williamson JR
    Diabetes; 1989 Oct; 38(10):1258-70. PubMed ID: 2507378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
    Tilton RG; Pugliese G; LaRose LS; Faller AM; Chang K; Province MA; Williamson JR
    J Diabet Complications; 1991; 5(4):230-7. PubMed ID: 1779018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal and microvascular effects of an aldose reductase inhibitor in experimental diabetes. Biochemical, functional and ultrastructural studies.
    Kassab JP; Guillot R; Andre J; Claperon N; Bellon G; Feldmann G; Peyroux J; Sternberg M
    Biochem Pharmacol; 1994 Aug; 48(5):1003-8. PubMed ID: 8093087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sorbinil prevents glomerular hyperperfusion in diabetic rats.
    Bank N; Mower P; Aynedjian HS; Wilkes BM; Silverman S
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F1000-6. PubMed ID: 2500028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galactose feeding causes glomerular hyperperfusion: prevention by aldose reductase inhibition.
    Bank N; Coco M; Aynedjian HS
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F994-9. PubMed ID: 2500030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sorbinil on glomerular structure and function in long-term-diabetic rats.
    Mauer SM; Steffes MW; Azar S; Brown DM
    Diabetes; 1989 Jul; 38(7):839-46. PubMed ID: 2525493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
    Gillon KR; Hawthorne JN; Tomlinson DR
    Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular filtration function in galactose-fed versus diabetic rats: the role of polyol pathway activity.
    Pugliese G; Tilton RG; Speedy A; Chang K; Province MA; Kilo C; Williamson JR
    Metabolism; 1990 Jul; 39(7):690-7. PubMed ID: 2114513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldose reductase and the development of renal disease in diabetic dogs.
    Kern TS; Engerman RL
    J Diabetes Complications; 1999; 13(1):10-6. PubMed ID: 10232704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR; Moriarty RJ; Mayer JH
    Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
    Beyer-Mears A; Ku L; Cohen MP
    Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of aldose reductase inhibition and dietary protein restriction on renal function in experimental diabetes mellitus.
    McCormack AJ; Hak LJ; Finn WF
    Ren Fail; 1991; 13(4):267-74. PubMed ID: 1780495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combined insulin and sorbinil treatment on diabetes-induced vascular dysfunction in rats.
    Pugliese G; Tilton RG; Speedy A; Oates PJ; Williamson JR
    Metabolism; 1994 Apr; 43(4):492-500. PubMed ID: 8159110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of polyol-pathway inhibition and dietary myo-inositol on glomerular hemodynamic function in experimental diabetes mellitus in rats.
    Goldfarb S; Ziyadeh FN; Kern EF; Simmons DA
    Diabetes; 1991 Apr; 40(4):465-71. PubMed ID: 2010046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
    Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
    Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin-diabetic rat.
    Cameron NE; Leonard MB; Ross IS; Whiting PH
    Diabetologia; 1986 Mar; 29(3):168-74. PubMed ID: 3084324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonosmotic diabetic cataracts.
    Malone JI; Lowitt S; Cook WR
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.